BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 33584692)

  • 1. Induction of Trained Immunity by Recombinant Vaccines.
    Covián C; Ríos M; Berríos-Rojas RV; Bueno SM; Kalergis AM
    Front Immunol; 2020; 11():611946. PubMed ID: 33584692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice.
    Céspedes PF; Rey-Jurado E; Espinoza JA; Rivera CA; Canedo-Marroquín G; Bueno SM; Kalergis AM
    Vaccine; 2017 Feb; 35(5):757-766. PubMed ID: 28065474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant BCG Vaccines Reduce Pneumovirus-Caused Airway Pathology by Inducing Protective Humoral Immunity.
    Soto JA; Gálvez NMS; Rivera CA; Palavecino CE; Céspedes PF; Rey-Jurado E; Bueno SM; Kalergis AM
    Front Immunol; 2018; 9():2875. PubMed ID: 30581437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with a recombinant bacillus Calmette-Guerin strain confers protective Th1 immunity against the human metapneumovirus.
    Palavecino CE; Céspedes PF; Gómez RS; Kalergis AM; Bueno SM
    J Immunol; 2014 Jan; 192(1):214-23. PubMed ID: 24319265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Recombinant BCG Vaccine Is Safe and Immunogenic in Neonatal Calves and Reduces the Clinical Disease Caused by the Respiratory Syncytial Virus.
    Díaz FE; Guerra-Maupome M; McDonald PO; Rivera-Pérez D; Kalergis AM; McGill JL
    Front Immunol; 2021; 12():664212. PubMed ID: 33981309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-neutralization of four paramyxoviruses by a human monoclonal antibody.
    Corti D; Bianchi S; Vanzetta F; Minola A; Perez L; Agatic G; Guarino B; Silacci C; Marcandalli J; Marsland BJ; Piralla A; Percivalle E; Sallusto F; Baldanti F; Lanzavecchia A
    Nature; 2013 Sep; 501(7467):439-43. PubMed ID: 23955151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycobacterium bovis BCG Given at Birth Followed by Inactivated Respiratory Syncytial Virus Vaccine Prevents Vaccine-Enhanced Disease by Promoting Trained Macrophages and Resident Memory T Cells.
    Wang Y; Ge F; Wang J; Li H; Zheng B; Li W; Chen S; Zheng X; Deng Y; Wang Y; Zeng R
    J Virol; 2023 Mar; 97(3):e0176422. PubMed ID: 36779760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired immune response to vaccination against infection with human respiratory syncytial virus at advanced age.
    Guichelaar T; Hoeboer J; Widjojoatmodjo MN; Reemers SS; van Els CA; Otten R; van Remmerden Y; Boes J; Luytjes W
    J Virol; 2014 Sep; 88(17):9744-50. PubMed ID: 24920795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate Immune Components that Regulate the Pathogenesis and Resolution of hRSV and hMPV Infections.
    Andrade CA; Pacheco GA; Gálvez NMS; Soto JA; Bueno SM; Kalergis AM
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32545470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant T cell immunity triggered by human Respiratory Syncytial Virus and human Metapneumovirus infection.
    González AE; Lay MK; Jara EL; Espinoza JA; Gómez RS; Soto J; Rivera CA; Abarca K; Bueno SM; Riedel CA; Kalergis AM
    Virulence; 2017 Aug; 8(6):685-704. PubMed ID: 27911218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge.
    Wang D; Phan S; DiStefano DJ; Citron MP; Callahan CL; Indrawati L; Dubey SA; Heidecker GJ; Govindarajan D; Liang X; He B; Espeseth AS
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28298602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational design of human metapneumovirus live attenuated vaccine candidates by inhibiting viral mRNA cap methyltransferase.
    Zhang Y; Wei Y; Zhang X; Cai H; Niewiesk S; Li J
    J Virol; 2014 Oct; 88(19):11411-29. PubMed ID: 25056882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in the development of virus-like particle vaccines against respiratory viruses.
    Quan FS; Basak S; Chu KB; Kim SS; Kang SM
    Expert Rev Vaccines; 2020 Jan; 19(1):11-24. PubMed ID: 31903811
    [No Abstract]   [Full Text] [Related]  

  • 14. Lung CD8+ T Cell Impairment Occurs during Human Metapneumovirus Infection despite Virus-Like Particle Induction of Functional CD8+ T Cells.
    Wen SC; Schuster JE; Gilchuk P; Boyd KL; Joyce S; Williams JV
    J Virol; 2015 Sep; 89(17):8713-26. PubMed ID: 26063431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and efficacy of alphavirus-derived replicon vaccines for respiratory syncytial virus and human metapneumovirus in nonhuman primates.
    Bates JT; Pickens JA; Schuster JE; Johnson M; Tollefson SJ; Williams JV; Davis NL; Johnston RE; Schultz-Darken N; Slaughter JC; Smith-House F; Crowe JE
    Vaccine; 2016 Feb; 34(7):950-6. PubMed ID: 26772634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Sendai virus recombinant vaccine expressing a gene for truncated human metapneumovirus (hMPV) fusion protein protects cotton rats from hMPV challenge.
    Russell CJ; Jones BG; Sealy RE; Surman SL; Mason JN; Hayden RT; Tripp RA; Takimoto T; Hurwitz JL
    Virology; 2017 Sep; 509():60-66. PubMed ID: 28605636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of temperature-sensitive human metapneumovirus strains that provide protective immunity in hamsters.
    Herfst S; de Graaf M; Schrauwen EJA; Sprong L; Hussain K; van den Hoogen BG; Osterhaus ADME; Fouchier RAM
    J Gen Virol; 2008 Jul; 89(Pt 7):1553-1562. PubMed ID: 18559924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A host-range restricted parainfluenza virus type 3 (PIV3) expressing the human metapneumovirus (hMPV) fusion protein elicits protective immunity in African green monkeys.
    Tang RS; Mahmood K; Macphail M; Guzzetta JM; Haller AA; Liu H; Kaur J; Lawlor HA; Stillman EA; Schickli JH; Fouchier RA; Osterhaus AD; Spaete RR
    Vaccine; 2005 Feb; 23(14):1657-67. PubMed ID: 15705469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A safe and efficient BCG vectored vaccine to prevent the disease caused by the human Respiratory Syncytial Virus.
    Rey-Jurado E; Soto J; Gálvez N; Kalergis AM
    Hum Vaccin Immunother; 2017 Sep; 13(9):2092-2097. PubMed ID: 28598702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cells in human Pneumovirus and Metapneumovirus infections.
    Guerrero-Plata A
    Viruses; 2013 Jun; 5(6):1553-70. PubMed ID: 23787776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.